Clearance is the most important pharmacokinetic parameter for determining the maintenance dose of a drug. It describes the efficiency with which the body eliminates drug from the systemic circulation and is defined as the volume of plasma completely cleared of drug per unit time, typically expressed in liters per hour or milliliters per minute. Clearance reflects the sum of all elimination processes, including metabolism and excretion, and dictates the steady-state concentration achieved during continuous or repeated dosing.
Definition and Core Concept
Clearance does not indicate how much drug is removed but rather the volume of plasma from which drug is irreversibly removed per unit time. For example, a clearance of 5 L per hour means that the drug is removed from 5 L of plasma each hour, regardless of the drug concentration. This is a first-order process for most drugs at therapeutic concentrations, meaning the rate of elimination is proportional to the plasma concentration. The fundamental equation relating clearance to dosing rate is: dosing rate equals clearance multiplied by the desired steady-state concentration.
Organ Clearance
Hepatic clearance represents drug elimination by liver metabolism and biliary excretion. The liver’s ability to clear a drug depends on hepatic blood flow, the intrinsic ability of hepatocytes to metabolize the drug, and the fraction of drug that is free and available for extraction. Drugs with a high hepatic extraction ratio are flow-limited, meaning their clearance approximates hepatic blood flow and is sensitive to changes in cardiac output or liver perfusion. Drugs with a low extraction ratio are capacity-limited, meaning their clearance depends primarily on intrinsic enzyme activity and protein binding.
Renal clearance represents drug elimination through the kidneys. The renal clearance of a drug is the sum of glomerular filtration and tubular secretion minus tubular reabsorption. Glomerular filtration contributes approximately 120 mL per minute of clearance for unbound drug in a healthy adult, while tubular secretion can add additional clearance through active transport processes. Renal impairment reduces clearance of renally eliminated drugs, requiring dose adjustment to prevent accumulation.
Total Body Clearance
Total body clearance is the sum of clearances from all eliminating organs, with hepatic and renal clearance being the dominant contributors for most drugs. The concept is additive: total clearance equals hepatic clearance plus renal clearance plus clearance from any other eliminating organs. For a drug that is entirely eliminated by the liver and kidneys, total body clearance reflects the combined function of both organs. Understanding the relative contribution of each organ guides dose adjustment in organ dysfunction.
Relationship to Half-Life and Volume of Distribution
Clearance and volume of distribution together determine the elimination half-life according to the formula t½ = 0.693 × Vd / CL. This relationship is crucial because it separates the concepts of elimination efficiency (clearance) and distribution space (Vd). A drug can have a long half-life due to either low clearance or large Vd, and these two scenarios have very different clinical implications. A long half-life due to low clearance means the drug is slowly removed from the body, while a long half-life due to large Vd means the drug is stored in tissues and slowly redistributes to plasma.
First-Order versus Zero-Order Elimination
Most drugs exhibit first-order elimination, where a constant fraction of drug is eliminated per unit time. The clearance remains constant regardless of concentration, and the plasma concentration declines exponentially. Zero-order elimination, also called saturation kinetics, occurs when elimination pathways become saturated at high drug concentrations. A constant amount of drug is eliminated per unit time rather than a constant fraction, and clearance decreases as concentration increases. This is characteristic of ethanol and of phenytoin at therapeutic concentrations. Zero-order kinetics makes dose titration particularly challenging because small dose increases can produce disproportionately large increases in steady-state concentration.
Clinical Applications
Clearance is the parameter used to calculate maintenance doses. The maintenance dose rate equals clearance multiplied by the target steady-state concentration. If clearance is reduced by half, the maintenance dose must also be reduced by half to avoid accumulation. This is the basis for dose adjustment in renal and hepatic impairment. Understanding clearance also helps predict the time course of drug accumulation, the effect of drug interactions on steady-state levels, and the duration of drug action after discontinuation.
